Regeneron Pharmaceuticals (REGN) Earnings (2009 - 2026)
Regeneron Pharmaceuticals (REGN) earnings from Jun 30, 2009 to Mar 31, 2026. The TTM Regeneron Pharmaceuticals (REGN) earnings is $4.42B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Regeneron Pharmaceuticals (REGN) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -1.69% |
| 3 Years TTM | +1.88% |
| 5 Years TTM | +2.01% |
| 10 Years TTM | +19.81% |
Annual Earnings change of Regeneron Pharmaceuticals (REGN)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $727M | -83.86% |
| 2025 | $4.50B | +2.09% |
| 2024 | $4.41B | +11.61% |
| 2023 | $3.95B | -8.87% |
| 2022 | $4.34B | -46.28% |
| 2021 | $8.08B | +129.86% |
| 2020 | $3.51B | +66.05% |
| 2019 | $2.12B | -13.44% |
| 2018 | $2.44B | +103.95% |
| 2017 | $1.20B | +33.84% |
| 2016 | $896M | +40.79% |
| 2015 | $636M | +88.11% |
| 2014 | $338M | -18.27% |
| 2013 | $414M | -44.85% |
| 2012 | $750M | -438.33% |
| 2011 | -$222M | +112.27% |
| 2010 | -$104M | +54.02% |
| 2009 | -$68M | -14.28% |
| 2008 | -$79M | N/A |
Comparison Regeneron Pharmaceuticals (REGN) five years earnings CAGR with competitors
Regeneron Pharmaceuticals (REGN) five years earnings CAGR is 2.01%.